Oral evidence transcript
| Published on: | Monday 4 December 2017 |
|---|---|
| Date: | Tuesday 17 October 2017 |
| Meeting on: | Tuesday 17 October 2017 |
| Part of event segment: | Untitled |
| Document ID: | 156387 |
Committees
Work packages
-
Life Sciences and the Industrial Strategy
Tuesday 18 July 2017 - Tuesday 18 July 2017
Witnesses
-
Dave Allen, Senior Vice President, Respiratory Disease R&D, GSK and Menelas Pangalos, Executive Vice President of Innovative Medicines and Early Development (IMED) Biotech Unit, AstraZeneca